Montero-Baker Miguel, Sommerset Jill, Miranda Jorge A
Hope Vascular & Podiatry Clinical Innovation Center, Houston, TX.
Advanced Vascular Centers, Portland, OR.
J Vasc Surg Cases Innov Tech. 2023 Apr 22;9(3):101160. doi: 10.1016/j.jvscit.2023.101160. eCollection 2023 Sep.
We report on two venous arterialization (VA) techniques for treatment of CLTI in patients traditionally considered as having no treatment options for standard arterial endovascular or surgical bypass procedures. Screening and the preprocedural workup findings are outlined as deciding factors in determining a patient's fitness for the two techniques, with a focus on careful preprocedure arterial duplex ultrasound and assessment for vein suitability. Cardiac and infection screening are also factors in determining patient suitability for VA. In addition, radiographic assessment for the presence of medial artery calcification, which is used as a marker of technical difficulty and is a predictor of poor outcomes, is required. Ultimately, anatomic factors are used to determine the decision between hybrid superficial VA and or endovascular deep VA. Those with an occluded anterior tibial artery and suitable great saphenous vein are prioritized to hybrid superficial VA, and those with an occluded posterior tibial artery to endovascular deep VA. Both procedures are described in detail in this report of vascular and surgical techniques.
我们报告了两种静脉动脉化(VA)技术,用于治疗传统上被认为无法进行标准动脉血管腔内或外科搭桥手术的慢性肢体威胁性缺血(CLTI)患者。筛查和术前检查结果被概述为决定患者是否适合这两种技术的因素,重点是仔细的术前动脉双功超声检查和静脉适用性评估。心脏和感染筛查也是决定患者是否适合VA的因素。此外,需要进行影像学评估以确定是否存在中膜动脉钙化,其用作技术难度的指标,也是预后不良的预测指标。最终,根据解剖学因素来决定采用混合浅表VA还是血管腔内深部VA。胫前动脉闭塞且大隐静脉合适的患者优先采用混合浅表VA,胫后动脉闭塞的患者则采用血管腔内深部VA。本血管和外科技术报告详细描述了这两种手术。